Gina Drosos may have one of the mostengaging manners in the beauty business,but make no mistake—this is a womanwho plays to win. As group president,global female beauty, of P&G Beauty& Grooming, she oversees a brand portfolio of almost$20 billion. Here, Drosos reveals her strategic vision forthe beauty business, and how she fires up her team toconsistently deliver a peak performance. How do you see the beauty industry evolving in the next twoto five years? Which opportunities excite you the most? One big trend has to do with the aging of the population,particularly combined with the blurring of health andbeauty. Antiaging medicine. Biomedical gerontology.Scientists trying to biologically slow down aging. It’s ahugely interesting area because it ranges all the way fromreally synthetic interventions that stimulate nerves or newbody parts or new organs to how we can leverage topicalproducts through genomics and gain a better understandingof high and low responders to different active ingredients.
Take Olay Pro-X. Our scientists did rocket sciencekind of research to identify biochemical pathways thatare active in younger skin, and then which ingredientswe can put into it that cause older skin to behave in thesame way. The advances that we’re already beginningto bring are really exciting, but it can go quite far. Stemcell research. Therapeutic cloning as a way to regeneratecells or even body parts. Some of the new approaches ourscientists are using with free radicals and looking at howantioxidants, insulin, oxytocin, even minerals can reversethe effects of damage.
A Stella McCartney sketch of a custom dress made from protein-based silk in partnership with biotech lab Bolt Threads. The dress will be displayed at The Museum of Modern Art's upcoming design exhibition, "Items: Is Fashion Modern?"